Compare Agilent Technologies Inc (A) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Visa Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Visa Inc trades at $362.71 (market cap $668.96B). The key difference: Visa Inc is far larger — about 15.9× Agilent Technologies Inc's market cap, and Visa Inc pays the higher dividend (0.74%). Which is the better fit depends on your goals.
| A | V | |
|---|---|---|
Market Cap | $42.00B | $668.96B |
Sector | Health | Financials |
52-Week High | $157.20 | $370.47 |
52-Week Low | $110.24 | $295.52 |
Enterprise Value | $43.55B | $679.54B |
Dividend Yield | 0.69% | 0.74% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Visa (V) trades at $362.82, up 0.09% on the day, with a bearish technical signal but strong fundamentals including a 50.78% net income margin and consistent earnings beats. Revenue grew to $40 billion in 2025, and the company is advancing in AI-driven commerce with initiatives like Intelligent Commerce Connect. The stock is supported by a consensus price target of $426.31, implying 17% upside.
The outlook is positive given Visa's profitability, analyst buy ratings (85%), and innovation in payments technology. Risks include competitive threats from fintech and stablecoins, as noted in recent news, and regulatory pressures. The stock offers long-term growth potential but faces headwinds from market volatility and evolving payment landscapes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
